Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)

by Huyen Tran, Shamir R Mehta, John W Eikelboom
Published 2006-12-01

Management of peripheral arterial disease in the elderly: focus on cilostazol

by Travis M Falconer, John W Eikelboom, Graeme J Hankey, Paul E Norman
Published 2008-03-01

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?

by Krishnan Shyamkumar, Jack Hirsh, Vinai C. Bhagirath, Jeffrey S. Ginsberg, John W. Eikelboom, Noel C. Chan
Published 2021-01-01

Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery

by Nathaniel R. Smilowitz, Navdeep Gupta, Yu Guo, Thomas S. Maldonado, John W. Eikelboom, Samuel Z. Goldhaber, Sripal Bangalore, Jeffrey S. Berger
Published 2017-07-01

Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial

by Vinai C. Bhagirath, John W. Eikelboom, Jack Hirsh, Michiel Coppens, Jeffrey Ginsberg, Thomas Vanassche, Fei Yuan, Noel Chan, Salim Yusuf, Stuart J. Connolly
Published 2017-07-01

Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial

by Maura Marcucci, Emmanuelle Duceppe, Yannick Le Manach, Clive Kearon, John W. Eikelboom, Kayla Pohl, Jessica Vincent, Saeed Darvish-Kazem, Sadeesh K. Srinathan, John D. D. Neary, Joel L. Parlow, Andrea Kurz, Peter L. Gross, Marko Mrkobrada, Kumar Balasubramanian, Daniel I. Sessler, P. J. Devereaux
Published 2020-07-01